Ocular Therapeutix (0OT) Hedge Fund Trading Activity
Trend: ▼ Hedge Funds Decreased Holdings by 51.7K Shares Last Quarter
Hedge Fund Holdings in 0OT
Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity
Activity
Star Ranking
| Hedge Fund Manager | Star Ranking | Firm | Activity | Holding Change | Value Reported | % of Portfolio | Follow |
|---|---|---|---|---|---|---|---|
 Andrew J.M. Spokes | Farallon Capital Management, L.L.C. | New | 100.00% | $218,520 | <0.01% | ||
| Michael Rockefeller | Woodline Partners LP | Added | 0.00% | $20,226,891 | 0.08% | ||
| Andrew Alkon | EntryPoint Capital, LLC | Not Changed | 0.00% | $145,740 | 0.06% | ||
 Kenneth Tropin | Graham Capital Management, L.P. | Reduced | -55.79% | $200,358 | <0.01% | ||
 Richard Driehaus | Driehaus Capital Management LLC | Sold Out | -100.00% | $6,297,673 | 0.00% |
FAQ
Which hedge funds hold Ocular Therapeutix?
The hedge funds that hold the most shares in Ocular Therapeutix are Michael Rockefeller, Andrew J.M. Spokes and Kenneth Tropin.
Are hedge funds buying or selling DE:0OT?
In the last quarter hedge funds have Decreased their holdings in Ocular Therapeutix by 51.7K shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Ocular Therapeutix stock?
Warren Buffet currently does not own shares in Ocular Therapeutix.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here